Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    Open Studies | "Poxviridae Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Poxviridae Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Conditions: Erysipelas;   Impetigo;   Herpes Zoster;   Molluscum Contagiosum;   Warts;   Tinea;   Melanoma;   Actinic Keratosis;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Interventions: Procedure: Screening;   Device: Tele-dermatology
2 Recruiting Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Condition: Hepatocellular Carcinoma (HCC)
Interventions: Biological: Pexastimogene Devacirepvec (Pexa Vec);   Drug: Sorafenib
3 Recruiting VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV
Condition: Smallpox Vaccine Adverse Reaction
Intervention: Biological: Vaccination with ACAM2000
4 Available Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
Conditions: Smallpox;   Monkeypox
Intervention: Drug: Tecovirimat
5 Recruiting A Dose Range-Finding Phase 2 Trial of a Botanical Drug for the Treatment of Molluscum Contagiosum in Pediatric Subjects
Condition: Molluscum Contagiosum
Interventions: Drug: 10% East Indian sandalwood oil cream;   Drug: Placebo Cream
6 Recruiting A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®
Condition: 18-42 Year Old Healthy Vaccinia-naïve Subjects
Interventions: Biological: MVA BN®;   Biological: ACAM2000®
7 Recruiting Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Condition: Lung Cancer
Intervention: Biological: GL-ONC1
8 Recruiting Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
Condition: Smallpox
Intervention: Biological: ACAM2000® smallpox vaccine
9 Recruiting GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Peritoneal Carcinomatosis;   Fallopian Tube Cancer
Intervention: Biological: GL-ONC1

Indicates status has not been verified in more than two years